|
Market Cap (17-May) $41,071,320 (780th) |
Close (30-Jun) $0.081 |
Volume (30-Jun) 2,818,974 |
Shortsold (13-Feb) 21,991 (0.00%) (605th) |
|
52w High $0.063 |
52w Low $0.037 |
P/E - |
EPS -0.01 |
PTX released this announcement to the ASX on 2 November 2022, 8:35. The announcement is not marked as price sensitive, and is 76 page(s) in length and 4.36MB in size.
You can view all announcements from PTX and see how they appear on a price chart on the announcements page.
At the date of this announcement, PTX was 0.139% short sold according to ASIC data. It was ranked the 458th most shorted stock on the ASX. It remains ranked 605th as of the latest reported data (13 February 2024).
| Other Recent Announcements from PTX | |
|---|---|
| Application for quotation of securities - PTX | 14 June 2023, 15:38 |
| Two PTX abstracts accepted at prestigious ISCT conference | 16 May 2023, 8:59 |
| Initial Director's Interest Notice | 15 May 2023, 14:31 |
| PTX Investor presentation and additional patient response | 2 November 2022, 8:35 |
| September 2022 Quarterly Update and Appendix 4C | 31 October 2022, 9:07 |
| Notice of Annual General Meeting/Proxy Form | 27 October 2022, 15:22 |
| PTX-100 Trial Update | 25 October 2022, 9:29 |
You must be logged in to post a reply.
Prescient Therapeutics 